Search results for "Amphotericin B"

showing 10 items of 61 documents

Anidulafungin in combination with amphotericin B against Aspergillus fumigatus.

2009

ABSTRACT We investigated the effects of anidulafungin alone and in combination with amphotericin B against Aspergillus fumigatus . Indifference was the only type of interaction observed in vitro. Anidulafungin at 1 and 5 mg/kg of body weight/day, amphotericin B at 1 mg/kg/day, and combination therapy prolonged the survival of mice with invasive aspergillosis. Anidulafungin at 5 mg/kg/day, alone and in combination with amphotericin B, reduced the kidney fungal burden. Overall, the combination was not superior to the most active single drug.

Settore MED/07 - Microbiologia E Microbiologia ClinicaAntifungal AgentsCombination therapymedicine.drug_classAntibioticsMicrobial Sensitivity TestsPharmacologyAspergillosisAnidulafunginKidneyAspergillus fumigatusMicrobiologyEchinocandinsMicePharmacotherapyAmphotericin BAmphotericin BmedicineAnimalsAspergillosisPharmacology (medical)Experimental TherapeuticsPharmacologyAspergillusbiologyAspergillus fumigatusaspergillus anidulafungin amphotericin BBrainbiology.organism_classificationmedicine.diseasebacterial infections and mycosesInfectious DiseasesAnidulafunginDrug Therapy Combinationmedicine.drugAntimicrobial agents and chemotherapy
researchProduct

Novel aspect of amphotericin B action: accumulation in human monocytes potentiates killing of phagocytosed Candida albicans.

1994

The influence of low doses of amphotericin B on the capacity of human monocytes to kill Candida albicans was investigated. Killing rates were quantified by a novel flow cytometric assay and were found to be 37% +/- 3% (standard error of the mean) after 3 h. Preincubation of monocytes for 6 to 20 h with low concentrations of amphotericin B (0.2 microgram/ml) resulted in a markedly augmented fungicidal capacity. Enhancement of killing was 80% +/- 11% (standard error of the mean) over that by the controls. This effect did not appear to be due to amphotericin B-dependent monocyte activation; the respiratory burst and expression of human leukocyte antigen-DR were unaltered, and no stimulation of…

Staphylococcus aureusPhagocytosisBiologyIn Vitro Techniquesmedicine.disease_causeMonocytesMicrobiologyPhagocytosisAmphotericin BAmphotericin BCandida albicansMacrophages AlveolarmedicineHumansPharmacology (medical)Candida albicansRespiratory BurstPharmacologyMonocyteHLA-DR Antigensbiology.organism_classificationCorpus albicansStimulation ChemicalRespiratory burstInfectious Diseasesmedicine.anatomical_structureStaphylococcus aureusIntracellularmedicine.drugInterleukin-1Research ArticleAntimicrobial agents and chemotherapy
researchProduct

Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients

2003

Patients with severe neutropenia lasting for more than 10 days, who develop fever and pulmonary infiltrates, are at high risk of treatment failure and infection-related death, under conventional broad-spectrum antibiotics. Early supplementation by a systemic antifungal therapy active against Aspergillus spp. has been shown to markedly improve their clinical outcome. Prognosis is significantly influenced by early identification of lung infiltrates by means of high-resolution thoracic computed tomography. Non-culture based diagnostic procedures using a highly sensitive Sandwich ELISA assay to detect circulating galactomannan, or PCR techniques to amplify circulating fungal DNA, may facilitate…

Voriconazolemedicine.medical_specialtyPathologymedicine.diagnostic_testbusiness.industryRespiratory diseaseHematologyGeneral MedicineNeutropeniamedicine.diseaseAspergillosisGastroenterologyBronchoalveolar lavageAmphotericin B deoxycholateInternal medicinemedicinebusinessFebrile neutropeniaMycosismedicine.drugAnnals of Hematology
researchProduct

Combination therapy in a model of pulmonary aspergillosis

2009

Summary. The current treatment for pulmonary aspergillosis, amphotericin B, is toxic and not always effective. This study was done to evaluate combinations of amphotericin B with other agents in an animal model of pulmonary aspergillosis. Sprague-Dawley rats were treated with cortisone acetate, infected intratracheally with 106 spores of Aspergillus fumigatus, and followed daily for survival. Mortality among controls started on day 2, and it was 80% by day seven, whereas therapy with amphotericin B resulted in survival of all animals. When given alone, ketoconazole, 5-fluorocytosine and rifampin did not improve survival. The combination of ketoconazole with amphotericin B resulted in comple…

biologyCombination therapyItraconazolebusiness.industryDermatologyGeneral MedicinePharmacologybiology.organism_classificationAspergillosismedicine.diseaseAspergillus fumigatusFlucytosineInfectious DiseasesAmphotericin BImmunologymedicineKetoconazolebusinessMycosismedicine.drugMycoses
researchProduct

Investigation of fungicidal activity of 3-piperazine-bis(benzoxaborole) and its boronic acid analogue

2014

3-Piperazine-bis(benzoxaborole) and its bis(phenylboronic acid) analogue were investigated in terms of their fungicidal activity. The study was carried out against five filamentous fungi: Aspergillus terreus, Fusarium dimerum, Fusarium solani, Penicillium ochrochloron and Aspergillus niger. 3-Piperazine-bis(benzoxaborole) revealed higher inhibitory activity towards the examined strains than standard antibiotic (amphotericin B), whereas bis(phenylboronic acid) proved to be inactive. The study unequivocally showed that the presence of the heterocyclic benzoxaborole system is essential for antifungal action of the examined compounds. Copyright © 2014 John Wiley & Sons, Ltd.

biologyStereochemistryAspergillus nigerfood and beveragesGeneral Chemistrybiology.organism_classificationInorganic Chemistrychemistry.chemical_compoundPiperazinechemistryAmphotericin BmedicineAspergillus terreusPhenylboronic acidFusarium solaniBoronic acidmedicine.drugPenicillium ochrochloronApplied Organometallic Chemistry
researchProduct

Model studies on a diastereoselective synthesis of the C(33)–C(37) fragment of Amphotericin B

2003

Abstract A new, short and highly diastereoselective synthetic route aiming at the C(33)–C(37) fragment of Amphotericin B has been developed. Studies with a model aldehyde (benzaldehyde) have given very promising results: the desired stereochemistry of all four stereocenters of the target molecule has been achieved with high diastereoselection. The stereochemistry of three key intermediates and the target segment has been confirmed by X-ray crystallography.

chemistry.chemical_classificationChemistryStereochemistryFragment (computer graphics)Organic ChemistryEnantioselective synthesisBiochemistryAldehydeStereocenterBenzaldehydechemistry.chemical_compoundAldol reactionAmphotericin BDrug DiscoverymedicineMoleculemedicine.drugTetrahedron
researchProduct

Description of an improved method for Blastocystis hominis culture and axenization

1996

An improved method for Blastocystis hominis culture and axenization was developed in the present study. Stool samples were cultured in prereduced Boeck-Drbohlav NHI modified medium (with several modifications) supplemented with antibiotics (0.4% ampicillin, 0.1% streptomycin, 0.0006% amphotericin B). Axenization was performed by the combination of partial purification of B. hominis by Ficoll-metrizoic acid gradient and inoculation in fresh medium containing active antibiotics against remaining bacteria. A total of 25 strains were obtained by this procedure. The time required for axenization ranged between 3 and 5 weeks. The generation time of axenic strains ranged from 6.6 to 12.1 h (mean +…

medicine.drug_classAntibioticsBlastocystis InfectionsMicrobiologyFecesAmpicillinAmphotericin BCentrifugation Density GradientmedicineAnimalsHumansBlastocystis hominisAxenicFecesBlastocystisGeneral VeterinarybiologyGeneral Medicinebiology.organism_classificationCulture MediaInfectious DiseasesStreptomycinInsect ScienceParasitologyCell DivisionBacteriamedicine.drugParasitology Research
researchProduct

Economic evaluation of caspofungin vs liposomal amphotericin B for empirical therapy of suspected systemic fungal infection in the German hospital se…

2007

As antifungal agents are frequently used in hematology and oncology, economic data on the empirical therapy of suspected systemic fungal infection are pivotal. Data were analyzed according to: (1) the rate of nephrotoxicity related to treatment with caspofungin in comparison to liposomal amphotericin B (L-AmB) from a randomized clinical trial, (2) the effect of nephrotoxicity on length of hospital stay from a European observational study, and (3) an example of total bottom-up cost in a department of hematology in Germany. All estimates include 95% confidence intervals (CI) using two-stage Monte Carlo simulation on binominal and Gaussian random variables from separate studies with comparable…

medicine.medical_specialtyAntifungal AgentsLiposomal amphotericin Blaw.inventionNephrotoxicitychemistry.chemical_compoundEchinocandinsLipopeptidesRandomized controlled trialDouble-Blind MethodlawCaspofunginBottom-up studyAmphotericin BInternal medicineAmphotericin BGermanymedicineHumansLongitudinal StudiesProspective StudiesProspective cohort studyIntensive care medicineNephrotoxicitybusiness.industryGeneral MedicineHematologybacterial infections and mycosesConfidence intervalEconomic evaluationchemistryMycosesLiposomesNumber needed to treatCosts and Cost AnalysisObservational studyOriginal ArticleCaspofunginbusinessmedicine.drugAnnals of Hematology
researchProduct

Possible reason for preferential damage to renal tubular epithelial cells evoked by amphotericin B

1996

An important determinant of nephrotoxicity, which is the major complication of long-term amphotericin B treatment, is dysfunction of distal tubular epithelial cells. The underlying cause for this rather selective damage to the cells is unknown. In the present investigation, it was shown that kidney epithelial cells were initially damaged by amphotericin B at concentrations of 2.5 to 10 micrograms/ml, as demonstrable by a dramatic drop in cellular K+ levels. Cells could recover from the initial toxic action of the polyene if they were kept in medium of neutral pH, and cellular K+ levels returned to normal after 6 h. However, the recovery mechanisms failed at lower pHs of 5.6 to 6.0. At low p…

medicine.medical_specialtyAntifungal AgentsLumen (anatomy)PharmacologyBiologyEpitheliumCell LineNephrotoxicitychemistry.chemical_compoundAdenosine TriphosphateAmphotericin BInternal medicineAmphotericin BLactate dehydrogenasemedicineAnimalsPharmacology (medical)Kidney Tubules DistalPharmacologyKidneyL-Lactate DehydrogenaseHydrogen-Ion ConcentrationMacaca mulattaIn vitroEpitheliumInfectious Diseasesmedicine.anatomical_structureEndocrinologychemistryToxicityPotassiumResearch Articlemedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Indomethacin treatment in amphotericin B induced nephrogenic diabetes insipidus.

1994

Nephrogenic diabetes insipidus (NDI) is a serious side effect of various drugs. Elevated renal prostaglandin E2 levels have been found in patients with lithium-induced NDI and have been implicated in the pathogenesis. We report the case of a patient who developed NDI following treatment with amphotericin B. Prostaglandin levels were elevated. Indomethacin had an antidiuretic effect and normalized prostaglandin levels.

medicine.medical_specialtySide effectVasopressinsIndomethacinProstaglandinDiabetes Insipidus NephrogenicKidneyLeukemia Myelomonocytic AcutePathogenesischemistry.chemical_compoundAmphotericin BInternal medicineAmphotericin BDrug DiscoveryMedicineHumansProstaglandin E2Genetics (clinical)business.industryGeneral MedicineMiddle Agedmedicine.diseaseNephrogenic diabetes insipidusDiuresisEndocrinologychemistryDiabetes insipidusToxicityProstaglandinsTobramycinMolecular Medicinelipids (amino acids peptides and proteins)Femalebusinessmedicine.drugThe Clinical investigator
researchProduct